Neuroendocrine cells in the prostate of the rat, guinea pig, cat, and dog

Prostate

Volumn 33, Issue 1, 1997, Pages 18-25

  Angelsen, Anders ^a,b   Mecsei, Reidun ^a   Sandvik, Arne K ^a   Waldum, Helge L ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cat; Dog; Guinea pig; Neuroendocrine cells; Prostate; Rat

Indexed keywords

ANIMAL CELL; ARTICLE; CAT; DOG; GROWTH REGULATION; GUINEA PIG; NEUROSECRETORY CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; RAT;

ANIMALS; CATS; DOGS; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; MALE; NEUROSECRETORY SYSTEMS; ORCHIECTOMY; PROSTATE; RATS; SILVER NITRATE; SILVER STAINING; TESTOSTERONE;

EID: 0030761056     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970915)33:1<18::AID-PROS4>3.0.CO;2-5     Document Type: Article

References (46)

1. Larsson LI: On the possible existence of multiple endocrine, paracrine and neuroendocrine messengers in secretory cell-systems. Invest Cell Pathol 1980;3:73-85.
2. Grube D: The endocrine cells of the digestive system: Amines, peptides and modes of action. Anat Embryol (Berl) 1986;175: 151-162.
3. Yamada T: Local regulatory actions of gastrointestinal peptides. In Johnson LR (ed): "Physiology of the Gastrointestinal Tract." New York: Raven Press, 1987:131-142.
4. Cutz E: Neuroendocrine cells of the lung: An overview of morphologic characteristics and development. Exp Lung Res 1982; 3:185-208.
5. Bishop A, Polac J: Gut endocrine and neural peptides. Endocr Pathol 1990;1:4-24.
6. di Sant'Agnese PA, de Mesy Jensen KL, Churucian CV, Agarwal MM: Human prostatic endocrine-paracrine (APUD) cells: Distributional analysis with a comparison of serotonin and neuron-specific enolase immunoreactivity and silver stains. Arch Pathol Lab Med 1985;109:607-612.
7. Abrahamsson PA, Wadstrøm LB, Alumets J, Falkmer S, Grimelius L: Peptide-hormone and serotonine-immunoreactive tumour cells in carcinoma of the prostate. Pathol Res Pract 1987; 182:298-307.
8. di Sant'Agnese PA, de Mesy Jensen KL, Churukian CJ, Agarwal MM: Human prostatic endocrine-paracrine (APUD) cells. Arch Pathol Lab Med 1985;109:607.
9. Davis NS, di Sant'Agnese PA, Ewing JF, Mooney RA: The neuroendocrine prostate: Characterization and quantification of calcitonin in the human gland. J Urol 1989;142:884-888.
10. Cockett AT, di Sant'Agnese PA, Gopiath P, Schoen SR, Abrahamsson PA: Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia. Urology 1993;42:512-519.
11. Abrahamsson PA, Falkner S, Falt K, Grimelius L: The course of neuroendocrine cells in prostatic carcinomas. Pathol Res Pract 1989;185:373-380.
12. di Sant'Agnese PA: Neuroendocrine differentiation in prostatic carcinoma. Hum Pathol 1992;23:287-296.
13. Angelsen A, Syversen U, Haugen OA, Stridsberg M, Mjølnerød OK, Waldum HL: Neuroendocrine differentiation in carcinomas of the prostate. Do neuroendocrine serum markers reflect immunohistochemical findings? Prostate 1997;30:1-6.
14. Bono AV, Pozzi E: Endocrine-paracrine cells in prostatic carcinoma and clinical course of the disease. Eur Urol 1985;11:195-198.
15. Abrahamsson PA, Falkner S, Fält K, Grimelius L: The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker". Pathol Res Pract 1989;185:373-380.
16. Cohen RJ, Glezerson G, Haffejee Z: Neuroendocrine cells - A new prognostic parameter in prostate cancer. Br J Urol 1991;68: 258-262.
17. Cohen MK, Arber DA, Coffield S, Keegan GT, McClintock J, Speights VO: Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression. Cancer 1994;74:1899-1903.
18. Aprikian A, Cordon Cardo C, Fair WR, Zhang ZF, Bazinett M, Hamdy SM, Reuter VE: Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol 1994;151:914-919.
19. Noordzij MA, van der Kwast TH, van Steenbrugge GJ, Hop WJC, Schröder FH: The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy. Int J Cancer 1995;62:252-258.
20. Håkanson R, Larsson L-I, Sjøberg N-O, Sundler F: Amine-producing endocrine-like cells in the epithelium of urethra and prostate of the guinea-pig. A chemical, fluorescence histochemical, and electron microscopic study. Histochemistry 1974;38: 259-270.
21. di Sant'Agnese PA, Davis NS, Chen M, de Mesy Jensen KL: Age-related changes in the neuroendocrine (endocrine-paracrine) cell population and the serotonin content of the guinea pig prostate. Lab Invest 1987;57:729-736.
22. Vittoria A, La Mura E, Budetta G, Paino G, Costagliola A, Cecio A: "Immunocitochimica delle Cellule a 5-HT nel Complesso Uretro-Prostatico di Bubalus Buffalus." Turin: Atti del 41° Convegno della Societa Italiana di Anatomia, 1986.
23. Hanyu S, Iwanaga T, Kano K, Fujita T: Distribution of serotonin-immunoreactive cells in the lower urinary tract of dogs. Am J Anat 1987;180:349-356.
24. Vittoria A, La Mura E, Cocca T, Cecio A: Serotonin-, somatostatin- and chromogranin A-containing cells of the urethroprostatic complex in the sheep. An immunocytochemical and immunofluorescent study. J Anat 1990;171:169-178.
25. Grimelius L: A silver nitrate stain for α-2-cells in human pancreatic islets. Acta Soc Med Ups 1968;73:243-270.
26. Solcia E, Capella C, Vasallo G: Lead-hematoxylin as a stain for endocrine cells. Significance of staining and comparison with other selective methods. Histochemistry 1969;20:116-126.
27. Dimaline R, Sandvik AK, Evans D, Forster ER, Dockray GJ: Food stimulation of histidine decarboxylase messenger RNA in rat gastric fundus. J Physiol (Paris) 1993;65:449-458.
28. Iacangelo A, Okayama H, Eiden LE: Primary structure of rat chromogranin A and distribution of its mRNA. FEBS Lett 1988; 227:115-121.
29. Dimaline R, Evans D, Forster ER, Sandvik AK, Dockray GJ: Control of gastric corpus chromogranin A messenger RNA abundance in the rat. Am J Physiol 1993;264:583-588.
30. Bosland MC: Adenocarcinoma, prostate, rat. In Jones TC, Mohr U, Hunt RD (eds.): "Genital System." Berlin: Springer-Verlag, 1987:252-260.
31. Pollard M, Luckert PH, Snyder D: Prevention of prostate cancer and liver tumors in L-W rats by moderate dietary restriction. Cancer 1989;64:686-690.
32. Noble RL: Prostate carcinoma in the Nb rat in relation to hormones. Int Rev Exp Pathol 1982;23:113-159.
33. Pollard MP, Luckert PH, Schmidt MA: Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate 1982;3:563-568.
34. Pour PM, Stepan K: Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine. Cancer Res 1987;47:5699-5706.
35. Bosland MC, Scherrenberg PM, Ford H, Dreef-van der Meulen HC: Promotion by testosterone of N-methyl-N-nitrosurea-induced prostatic carcinogenesis in rats. Proc Am Assoc Cancer Res 1989;30:272.
36. Shirai T, Tamano S, Kato T, Iwasaki S, Takahashi S, Ito N: Induction of invasive carcinomas in the accessory sex organs other than ventral prostate of rats given 3,2′-dimethyl-4-amino-biphenyl and testosterone propionate. Cancer Res 1991;51:1264-1269.
37. Pollard M, Luckert PH: Promotional effects of testosterone and dietary fat on prostate carcinogenesis in genetically susceptible rats. Prostate 1985;6:1-5.
38. Pollard M, Luckert PH: Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-metylurea and testosterone. JNCI 1986;77:583-587.
39. Pollard M, Luckert PH: Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: A model system. Prostate 1987;11: 219-227.
40. Bosland MC, Dreef-van der Meulen HC, Sakumar S, Ofner P, Leav I, Han X, Liehr JG: The role of hormones. In Harris CC (ed): "Multistage Carcinogenesis." Tokyo: Japan Sci Soc Press, 1992:109-123.
41. Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD: Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986;324:476-478.
42. Koneccki DS, Benedum UM, Gerdes H-H, Huttner WB: The primary structure of human chromogranin A and pancreastatin. J Biol Chem 1987;262:17026-17030.
43. Effendic S, Tatemoto K, Mutt V, Quan C, Chang D, Østenson C-G: Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 1987;84:7257-7260.
44. Bishop AE, Bretherton-Watt D, Hamid QA, Fahey M, Shepherd N, Valentino K, Tatemoto K, Ghatei MA, Bloom SR, Polak JM: The occurrence of pancreastatin in tumors of diffuse neuroendocrine system. Mol Cell Probes 1988;2:225-235.
45. Mullis KB, Fallora F: Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Methods Enzymol 1987; 155:335-350.
46. Krijnen JLM, Janssen PJA, Ruizeveld de Winter JA, van Krimpen H, Schroder FH: Do neuroendocrine cells in prostate cancer express androgen receptor? Histochemistry 1993;100:393-398.